Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFC Energy Regulatory News (AFC)

  • There is currently no data for AFC

Grant of Options

20 Mar 2015 15:53

RNS Number : 0921I
AFC Energy Plc
20 March 2015
 

AFC Energy plc

 

 ("AFC Energy" or the "Company")

Grant of Share Options

AFC Energy announces that further to his appointment to the Company's board of directors on 16 September 2014 the board of AFC Energy has, today, granted Chris Tawney an option over a total of 500,000 new ordinary shares of 0.1p each in the Company ("Ordinary Shares") (the "Option").

The Option has been granted under the rules of the AFC Energy Plc 2007 Share Option Scheme. The purpose of the Options is to incentivise, retain and attract employees.

The Options are exercisable at a price of 17p pence per Ordinary Share. The Option shall vest on the 3rd anniversary of the date of grant of the Option and is conditional upon:

· a successful demonstration of the large-scale fuel cell system, defined as a system operating for at least 90 days without requiring a change of electrode cartridges;

· the Company's market capitalisation reaching £90 million or greater for 30 consecutive days; and

· the Company being either cash flow positive from operating activities over any rolling 12 month period; or profitable over any rolling 12 month period, at the profit before tax level.

Following the grant of the Option, Chris Tawney's interests in the Company will be as follows:

Name

Title

Total no. of options held over ordinary shares

Total no. of warrants held over ordinary shares

Total ordinary shares

Chris Tawney

Finance Director

500,000

-

50,000

Following the issue of the Option there will be EMI options over 7,655,000 Ordinary Shares in issue, representing approximately 2.65% per cent of the current issued share capital of the Company, and 7,047,800 warrants over Ordinary Shares in issue, representing approximately 2.44 per cent of the current issued share capital of the Company.

For further information, please contact:

AFC Energy plc

Adam Bond (CEO)

 

 

+44 (0) 20 3697 1209

Zeus Capital Limited - Nominated Adviser and Joint Broker

John Depasquale, John Treacy 

Alex Davies, John Goold

 

+44 (0) 20 7533 7727

 

M C Peat & Co LLP - Joint Broker

Charlie Peat

 

+44 (0) 20 7104 2334

Lionsgate Communications - Public Relations

Jonathan Charles, Rachel Rigby

 

 

+44 (0) 20 3697 1209

 

About AFC Energy

AFC Energy plc is fast approaching commercialisation for its proven low-cost alkaline fuel cell system ("KORE"), which converts hydrogen into 'clean' electricity. AFC's key project POWER-UP will demonstrate the world's largest alkaline fuel cell system at Air Products' industrial gas plant in Stade, Germany. The date for the demonstration of the 240kW KORE system has been fast tracked to December 2015, representing the final phase of AFC's pre-commercialisation technical development programme and creating the platform for the Company's global commercial fuel cell deployment. For further information, please visit our website: www.afcenergy.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSJMMATMBATBBA
Date   Source Headline
12th May 20261:28 pmRNSChange of Name to H-Power plc
30th Apr 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSBlock Listing Return and Total Voting Rights
16th Apr 202612:48 pmRNSResult of AGM
23rd Mar 20267:02 amRNSDirectorate Remuneration and Total Voting Rights
23rd Mar 20267:00 amRNSNotice of 2026 AGM and Change of Name
25th Feb 20267:00 amRNSFinal Audited Results
18th Feb 20267:00 amRNSEA allows AFC to sell hydrogen produced by cracker
10th Feb 20267:00 amRNSJoint Development Agreement with Komatsu Ltd.
9th Feb 20267:00 amRNS-REquipment Demonstration Day For Retail Investors
30th Jan 20267:00 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSOperational Update
20th Jan 20267:00 amRNSNotice of Results
17th Dec 20257:00 amRNSAdmission of Shares and Total Voting Rights
6th Nov 20257:00 amRNSTrading Update for Year Ended 31 October 2025
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSBlock Listing Return and Total Voting Rights
21st Oct 20257:00 amRNS-RAFC CTO to Chair new UK Ammonia Alliance group
15th Oct 20257:00 amRNSDirector/PDMR Shareholding
10th Oct 20257:00 amRNSAGM Resolution Vote Update and Change of Broker
15th Sep 20257:00 amRNS-RAppointment of Chief Strategy Officer
14th Aug 202512:29 pmRNSDirector/PDMR Shareholding
14th Aug 202511:50 amRNSDirector/PDMR Shareholding
13th Aug 20255:00 pmRNSDirector/PDMR Shareholding
7th Aug 202510:31 amRNSGeneral Meeting Results and PDMR Shareholding
1st Aug 20257:00 amRNSGrant of Share Options
21st Jul 20255:29 pmRNSRetailBook Offer Result & General Meeting Notice
18th Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
17th Jul 20258:00 amRNSResults of Oversubscribed Placing and Subscription
16th Jul 20256:21 pmRNSInterim Results for half year 2025 – Replacement
16th Jul 20255:36 pmRNSRetailBook Offer
16th Jul 20255:36 pmRNSProposed Placing & Subscription & RetailBook Offer
16th Jul 20255:36 pmRNSInterim Results for the half year to 30 April 2025
4th Jul 20257:00 amRNSNew JV with Industrial Chemicals Group
30th Jun 20257:00 amRNSTotal Voting Rights
13th Jun 20257:00 amRNSOperational Update
4th Jun 202512:06 pmRNSJoint Development Agreement
30th May 20257:00 amRNSTotal Voting Rights
7th May 202511:43 amRNSDirector/PDMR Shareholding
6th May 20253:59 pmRNSDirector/PDMR Shareholding
6th May 20252:05 pmRNSDirector/PDMR Shareholding
2nd May 20252:21 pmRNSDirector/PDMR Shareholding
1st May 20255:40 pmRNSDirector/PDMR Shareholding
25th Apr 20257:00 amRNSBlock Listing Return
23rd Apr 20253:40 pmRNSDirector/PDMR Shareholding
23rd Apr 20251:00 pmRNSAnnual General Meeting Results
28th Mar 20257:00 amRNSNotice of 2025 Annual General Meeting
27th Mar 202510:01 amRNSDirector/PDMR Shareholding
26th Mar 20252:27 pmRNSDirector/PDMR Shareholding
19th Mar 202511:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.